Avella Recalls Fentanyl Syringes Due to Potential Leakage and Sterility Concerns
Avella of Deer Valley is recalling 120 fentanyl syringes due to potential bag leakage and lack of assurance of sterility.
What this means for you
Illness, injury, or structural failure has been reported. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: The recall is classified as FDA Class II, and the hazard involves a lack of assurance of sterility in a parenteral medication, which poses a significant risk of serious injury or infection.
Plain-English summary
Avella of Deer Valley, Inc. is recalling 120 single-dose syringes of fentanyl (10 mcg per mL) in 0.95 Sodium Chloride, USP. The product was prepared for Hunt Regional Medical Center by Advanced Pharma. The recall was initiated due to a lack of assurance of sterility, specifically caused by potential leakage of the bags.
The affected product is identified by NDC 15082-210-70. Specific lot numbers and beyond-use dates are listed in the recall documentation, including lots from May and June 2018. The distribution pattern is listed as nationwide in the USA, though the product was prepared for a specific medical center.
Consumers and healthcare providers should check their inventory for the specific lot numbers and beyond-use dates listed in the official recall notice. If the product is found, it should be quarantined and returned to the supplier or destroyed according to local regulations. Patients who have received this medication should consult their healthcare provider if they have concerns about the sterility of the product.
The recalled product
- Product
- fentaNYL (10 mcg per mL) in 0.95 Sodium Chloride, USP QS 1mL. Volume 1mL. Single dose Syringe. For: Hunt Regional Medical Center, By: Advanced Pharma, 9265 Kirby Dr,., Houston, TX 77054. NDC 15082-210-70
- Manufacturer
- Avella of Deer Valley, Inc. Store 38
- Category
- Drug — Injectable Medication
- Affected units
- 120
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (8)
- Lot # 5/3/18 0317 142-21070S
- BUD 8/1/2018
- 5/10/18 0512 144-21070S
- BUD 8/8/2018
- 6/1/18 0305 142-21070S
- BUD 8/30/2018
- 6/4/18 0505 252-21070S
- BUD 9/2/2018.
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 38 recalled by Avella of Deer Valley, Inc. Store 38 under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 38 products in this recall →Related recalls
Same manufacturer · Avella of Deer Valley, Inc. Store 38
See all →- SevereAvella Recalls Povidone Iodine Ophthalmic Solution Due to Sterility Concerns
FDA (Drugs) · 2019-10-30
- SevereAvella Recalls Bevacizumab Prefilled Syringes Due to Sterility Concerns
FDA (Drugs) · 2019-06-05
- ModerateAvella recalls magnesium sulfate bags with incorrect barcode expiration dates
FDA (Drugs) · 2019-02-20
- ModerateAvella Recalls Labetalol Syringes Due to Incorrect Barcode Expiration Dates
FDA (Drugs) · 2019-02-20
- ModerateAvella recalls magnesium sulfate bags with incorrect barcode expiration dates
FDA (Drugs) · 2019-02-20
Same hazard · sterility
See all →- SevereRegeneron Recalls Libtayo Injection Due to Sterility Assurance Concerns
FDA (Drugs) · 2026-08-26
- SeverePrestige Recalls Clear Eyes Maximum Itchy Eye Relief Due to Sterility Concerns
FDA (Drugs) · 2026-08-19
- SevereROHTO Cooling Eye Drops Recalled Over Sterility Assurance Concerns
FDA (Drugs) · 2026-07-29
- HighROHTO Cooling Eye Drops Recalled Over Sterility Assurance Concerns
FDA (Drugs) · 2026-07-29
- SevereFDA Recalls ROHTO OPTIC GLOW Eye Drops Over Sterility Concerns
FDA (Drugs) · 2026-07-29